MedTrace Logo

Influenza Challenge Study in Healthy Volunteers

NCT02746211 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-04-21

No results posted yet for this study

Summary

A study to determine the infectious titre of an Influenza A (H1N1) (A/New Caledonia/20/99) virus for use in other Influenza challenge studies for the development of Influenza vaccines, antiviral agents and to better understand the host response to Influenza infection.

Conditions

Interventions

BIOLOGICAL

High Titre Influenza virus

High Titre Influenza virus

BIOLOGICAL

Medium - High Influenza virus

Medium - High Influenza virus

BIOLOGICAL

Medium Low Titre Influenza virus

Medium Low Titre Influenza virus

BIOLOGICAL

Low titre

Low titre

Sponsors & Collaborators

  • Hvivo

    lead INDUSTRY

Principal Investigators

  • Robert Lambkin-Williams, PhD · 020 7756 1300

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02746211 on ClinicalTrials.gov